Shijiazhuang Puli Pharmaceutical Co., Ltd. was established in 2006 and is located in Xinzhaidian Industrial Zone, Zhaoxian, Shijiazhuang City with a registered capital of 21 million yuan. The main products include raw materials cimetidine, metformin hydrochloride; pharmaceutical intermediate cimetidine dimethic acid shrinkage; pharmaceutical excipients aspartatan, etc. The raw material cimetidine accounts for the largest market share in the world, and the market share of metformin hydrochloride is the second in the country.

The company is a member unit of Shijiazhuang Medical Association and the president unit of Zhaoxian Entrepreneurs Association. Since 2014, it has been rated as one of the top ten industrial units and a taxpayer in Zhaoxian County many times. It has been rated as a "civilized unit" by the municipal and county governments many times, and has been rated as an "advanced unit of production safety" by the Shijiazhuang Municipal Safety Committee many times. In 2016, it was recognized as a "high-tech enterprise" by the Hebei Provincial Department of Science and Technology, and in June 2017, it was recognized as a "small science and technology giant" by the Hebei Provincial Department of Industry and Information Technology and the Shijiazhuang Municipal Bureau of Industry and Information Technology as a "R&D Center (B-level)" by the Hebei Provincial Department of Industry and Information Technology, and in November it was recognized as a "specialized, precise, and new" small and medium-sized enterprise by the Hebei 

During the COVID-19 pandemic, Puli Pharmaceutical actively donated money and materials, donated 200,000 yuan in cash to the Zhao County Red Cross Society, donated a thermometer worth 25,000 yuan, donated tons of disinfectant to several villages and towns, and donated food and supplies to frontline personnel in the fight against the epidemic.